Portal de Periódicos da CAPES

Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India

2014; Elsevier BV; Volume: 4; Issue: 2 Linguagem: Inglês

10.1016/j.jceh.2014.05.006

2213-3453

P. Puri, Anil C. Anand, Vivek A. Saraswat, Subrat Kumar Acharya, Radha K. Dhiman, Rakesh Aggarwal, Shivram Prasad Singh, Deepak Amarapurkar, Anil Arora, M. B. Chhabra, Kamal Chetri, Gourdas Choudhuri, V. K. Dixit, Ajay Duseja, Ajay K. Jain, Dharmesh Kapoorz, Premashis Kar, Abraham Koshy, Ashish Kumar, Kaushal Madan, Sri Prakash Misra, Mohan Prasad, Aabha Nagral, Amarendra S. Puri, Jeyamani Ramachandran, Sanjiv Saigal, Shiv Kumar Sarin, Samir Shah, Praveen Sharma, Ajit Sood, Sandeep Thareja, Manav Wadhawan,

Hepatitis B Virus Studies

Globally, around 150 million people are infected with hepatitis C virus (HCV). India contributes a large proportion of this HCV burden. The prevalence of HCV infection in India is estimated at between 0.5% and 1.5%. It is higher in the northeastern part, tribal populations and Punjab, areas which may represent HCV hotspots, and is lower in western and eastern parts of the country. The predominant modes of HCV transmission in India are blood transfusion and unsafe therapeutic injections. There is a need for large field studies to better understand HCV epidemiology and identify high-prevalence areas, and to identify and spread awareness about the modes of transmission of this infection in an attempt to prevent disease transmission.